BAYER VIETNAM LIMITED (CÔNG TY TNHH BAYER VIỆT NAM), a fully foreign-invested enterprise in Vietnam, has been a leading player in the agrochemical and pharmaceutical industries since its establishment in 1997. With Business ID and Tax Code 3600359484, the company is headquartered at Lot 118/4, Amata Industrial Park, Bien Hoa City, Dong Nai Province, and operates regional offices in Ho Chi Minh City, Hanoi, and Binh Duong.

This limited liability company is jointly owned by BAYER AG (Germany, 51.22%) and BAYER S.A.S (France, 48.78%). It is led by General Director Mr. Ingo Brandenburg, with Mr. Maximilian Rummert serving as Finance Director and Mr. Kieu Tan Quy as Chief Accountant. The company employs around 600 staff and is known for its manufacture and distribution of fungicides, herbicides, insecticides, hybrid seeds, and consumer health products.

Financial Performance: Falling Across the Board

In 2023, BAYER VIETNAM LIMITED experienced a significant contraction in financial performance across multiple indicators:

• Revenue dropped by 13.34%, from USD 213.9 million in 2022 to USD 185.4 million.

• Net profit plummeted by 41.08% to USD 7.95 million, continuing a declining trend over three years.

• Total assets fell sharply by 21.21% to USD 104.8 million.

• Owner’s equity decreased by 4.04%, reaching USD 64.9 million.

• Working capital shrank slightly by 4.24%, though it remains relatively healthy at USD 55.7 million.

This performance contrasts sharply with the company’s stronger results in 2022, raising questions about operational efficiency, market conditions, or internal cost structures. The sustained decline in profit and equity over the last three years is particularly concerning, even for a mature multinational with long-term roots in Vietnam.

Risk Management Perspective: Mature Operations with Shrinking Margins

While BAYER VIETNAM LIMITED benefits from the global brand recognition and operational backing of its parent companies in Germany and France, the recent financials underscore mounting pressure in Vietnam’s agrochemical and healthcare product segments. A 41% drop in profit in one year, paired with declining assets and equity, points to potential challenges in product competitiveness, input costs, or market saturation.

Businesses considering commercial partnerships or financial arrangements with the company should conduct Litigation Searches and review Private Financial Data to determine the root causes of this downward trend. Although the company remains active and structurally sound, the narrowing financial margins suggest that it is navigating a more constrained operating environment.